´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2023³â Á¦18Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2023-06-02
±³À°ÀÏÀÚ : 2023-06-02
±³À°Àå¼Ò : ½ºÀ§½º±×·£µåÈ£ÅÚ ÄÁº¥¼Ç¼¾ÅÍ 4F ÄÁº¥¼ÇȦ
±³À°ÁÖÁ¦ : ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2023³â Á¦18Â÷ Çмú´ëȸ (2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Áø´ÜÀ¯ÀüÇÐȸ
´ã´çÀÚ : Á¤¹Ì¼±
¿¬¶ôó : 02-772-9004
À̸ÞÀÏ : ksgd.office@gmail.com
±³À°Á¾·ù : Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀÎ : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 12 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 160,000¿ø
ºñ°í »çÀüµî·Ïºñ : Á¤È¸¿ø 8¸¸¿ø(Àü¹®ÀÇ/±³¼ö/±âŸ) Á¤È¸¿ø 6¸¸¿ø(Àü°øÀÇ/ÀÓ»óº´¸®»ç), Âü°¡È¸¿ø 12¸¸¿ø(Àü¹®ÀÇ), 7¸¸¿ø(Àü°øÀÇ/ÀÓ»óº´¸®»ç/Çлý/¿¬±¸¿ø µî), 15¸¸¿ø(»ê¾÷°è) ÇöÀåµî·Ïºñ: Á¤È¸¿ø 9¸¸¿ø(Àü¹®ÀÇ/±³¼ö) Á¤È¸¿ø 7¸¸¿ø(Àü°øÀÇ/ÀÓ»óº´¸®»ç/Çлý/¿¬±¸¿ø), Âü°¡È¸¿ø 13¸¸¿ø(Àü¹®ÀÇ), 8¸¸¿ø(Àü°øÀÇ/ÀÓ»óº´¸®»ç/Çлý/¿¬±¸¿ø µî), 16¸¸¿ø(»ê¾÷°è)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06¿ù 02ÀÏ ¼¼¼ÇA(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇAȦ) 09:30~10:00 Empowering personalized healthcare with automated annotation of NGS result ¼Èñ¿ø(Çѱ¹·Î½´Áø´Ü)
±³À°½Ã°£ 06¿ù 02ÀÏ ¼¼¼ÇA(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇAȦ) 10:00~10:30 High Quality Human Whole Genome Sequencing at Scale for National Programs Gabriel Kolle(´Ù¿ì¹ÙÀÌ¿À¸ÞµðÄ«&ÀÏ·ç¹Ì³ª)
Åä·Ð 06¿ù 02ÀÏ ¼¼¼ÇA(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇAȦ) 10:30~10:40 ÁúÀÇÀÀ´ä Q&A ( )
±³À°½Ã°£ 06¿ù 02ÀÏ ¼¼¼ÇA(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇAȦ) 11:00~12:00 Transposons and Somatic Mutations: Next Frontiers in Genomic Medicine Eunjung Alice Lee(Assistant Professor Division of Genetics and GenomicsBoston Children)
±³À°½Ã°£ 06¿ù 02ÀÏ ¼¼¼ÇA(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇAȦ) 12:00~13:00 Past, Present, and Future of Human Genome Analysis ÃÖ¹«¸²(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06¿ù 02ÀÏ ¼¼¼ÇA(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇAȦ) 13:10~13:40 Molecular Findings and Testing in Lymphoid Neoplasms Classification ÀÌÁ¾¹Ì(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 02ÀÏ ¼¼¼ÇA(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇAȦ) 13:40~14:10 Diagnostic Approach for Myeloid Neoplasms According to ICC and 5th WHO Classification: Focusing on Genetic Findings Ãß´ëÇö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06¿ù 02ÀÏ ¼¼¼ÇA(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇAȦ) 14:10~14:40 Molecular Findings and Testing in Germline Predisposition ±èÈ«°æ(Áß¾ÓÀÇ´ë)
Åä·Ð 06¿ù 02ÀÏ ¼¼¼ÇA(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇAȦ) 14:40~14:50 ÁúÀÇÀÀ´ä Q&A ( )
±³À°½Ã°£ 06¿ù 02ÀÏ ¼¼¼ÇA(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇAȦ) 15:10~15:40 The Integration of Phenotype-Genotype Information in Interpretation ±èº¸¿¬(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06¿ù 02ÀÏ ¼¼¼ÇA(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇAȦ) 15:40~16:10 Interpretation using the FBN1 and LDLR ClinGen Guidelines ¼ÕÁö¿¬(ÀÌ¿øÀÇ·áÀç´Ü)
±³À°½Ã°£ 06¿ù 02ÀÏ ¼¼¼ÇA(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇAȦ) 16:10~16:40 Interpretation of Mitochondrial Disorders using Next-Generation Sequencing ±èÀ±Á¤(¿¬¼¼ÀÇ´ë)
Åä·Ð 06¿ù 02ÀÏ ¼¼¼ÇA(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇAȦ) 16:40~16:50 ÁúÀÇÀÀ´ä Q&A ( )
±³À°½Ã°£ 06¿ù 02ÀÏ ¼¼¼ÇB(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇDEȦ) 09:30~10:00 Cancer Signature Ensemble Integrating cfDNA Methylation, Copy Number, and Fragmentation Facilitates Multi-Cancer early Detection ±è¼ö¿¬(¾ÆÀÌ¿¥ºñµð¿¢½º)
±³À°½Ã°£ 06¿ù 02ÀÏ ¼¼¼ÇB(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇDEȦ) 10:00~10:30 Precision Medicine Approaches by Using Hereditary Cancer Syndrome Panel ÀÌ°æ¾Æ(¿¬¼¼ÀÇ´ë)
Åä·Ð 06¿ù 02ÀÏ ¼¼¼ÇB(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇDEȦ) 10:30~10:40 ÁúÀÇÀÀ´ä Q&A ( )
±³À°½Ã°£ 06¿ù 02ÀÏ ¼¼¼ÇB(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇDEȦ) 12:00~13:00 Diagnostic Utility of CytoScan Xon array ¼³Ã¢¾È(GCÁö³ð)
±³À°½Ã°£ 06¿ù 02ÀÏ ¼¼¼ÇB(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇDEȦ) 13:10~13:40 Ä¡ÁÖÁúȯ ¿¬°ü ±¸° ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È Áö¼÷(¾ÆÁÖÀÇ´ë Ä¡°úÇб³½Ç)
±³À°½Ã°£ 06¿ù 02ÀÏ ¼¼¼ÇB(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇDEȦ) 13:40~14:10 È£Èí±â °Ëü ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È°ú Áúȯ°úÀÇ ¿¬°ü¼º ÀÌÇϳª(°í·Á´ëÇб³ ¹ÙÀÌ¿À½Ã½ºÅÛÀÇ°úÇкÎ)
±³À°½Ã°£ 06¿ù 02ÀÏ ¼¼¼ÇB(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇDEȦ) 14:10~14:40 Microbiome in female genital tract ±è¿µÁÖ(ÀÌÈÀÇ´ë »êºÎÀΰú)
Åä·Ð 06¿ù 02ÀÏ ¼¼¼ÇB(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇDEȦ) 14:40~14:50 ÁúÀÇÀÀ´ä Q&A ( )
±³À°½Ã°£ 06¿ù 02ÀÏ ¼¼¼ÇB(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇDEȦ) 15:10~15:40 Application of Optical Genome Mapping for Detection and Characterization of Constitutional and Somatic Structural Variations ¿øµ¿ÁÖ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06¿ù 02ÀÏ ¼¼¼ÇB(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇDEȦ) 15:40~16:10 Introduction to Exon Level Chromosome Microarray ¹Î¼ºÈñ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06¿ù 02ÀÏ ¼¼¼ÇB(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇDEȦ) 16:10~16:40 Ç÷¾×¾Ï¿¡¼ÀÇ CMA Àû¿ë ¼³Ã¢¾È(³ì½ÊÀÚÁö³ð)
Åä·Ð 06¿ù 02ÀÏ ¼¼¼ÇB(½ºÀ§½º±×·£µåÈ£ÅÚ 4F ÄÁº¥¼ÇDEȦ) 16:40~16:50 ÁúÀÇÀÀ´ä Q&A ( )